In an era where gene therapy is rapidly reshaping our approach to treating complex diseases, XyloCor Therapeutics, a clinical-stage biopharmaceutical company, is standing at the forefront of innovation. With their groundbreaking gene therapies for cardiovascular disease, they are poised to revolutionize patient care. Now, their ambitious journey has received a significant boost from the global […]
